LEI 5493005D4SWG5IWHRB32

PFIZER LIMITED

Group parent: PFIZER INC.PFE · UN

Awards tracked

62

Value

€27,000

Countries

GB

Download sample CSV

Contract awards & public grants

FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE → PFIZER LIMITED

European Commission · GB · Grant · 2026-06-02

—

Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies → PFIZER LIMITED

European Commission · GB · Grant · 2025-11-03

—

Collaborative Action and Research for Engagement, Persistence and Adherence in Treatment & Health → PFIZER LIMITED

European Commission · GB · Grant · 2025-05-08

—

Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG → PFIZER LIMITED

European Commission · GB · Grant · 2025-04-28

—

Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare envi → PFIZER LIMITED

European Commission · GB · Grant · 2024-12-18

—

Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT) → PFIZER LIMITED

European Commission · GB · Grant · 2024-12-16

—

REpresentative Clinical Research - ADvancing Inclusivity in Europe → PFIZER LIMITED

European Commission · GB · Grant · 2024-12-05

—

Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing → PFIZER LIMITED

European Commission · GB · Grant · 2024-12-05

—

Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance → PFIZER LIMITED

European Commission · GB · Grant · 2021-11-09

—

Optimal treatment for patients with solid tumours in Europe through Artificial intelligence → PFIZER LIMITED

European Commission · GB · Grant · 2021-10-18

—

Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies → PFIZER LIMITED

European Commission · GB · Grant · 2021-10-13

—

FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem → PFIZER LIMITED

European Commission · GB · Grant · 2021-10-11

—

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe → PFIZER LIMITED

European Commission · GB · Grant · 2021-09-27

—

Real World Handling of Protein Drugs - Exploration, Evaluation and Education → PFIZER LIMITED

European Commission · GB · Grant · 2021-07-05

—

Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States → PFIZER LIMITED

European Commission · GB · Grant · 2021-06-29

—

Preparing for RSV Immunisation and Surveillance in Europe → PFIZER LIMITED

European Commission · GB · Grant · 2021-05-21

—

Add medical genetic solutions to RESOLUTE (REsolution) → PFIZER LIMITED

European Commission · GB · Grant · 2021-05-18

—

Central Repository for Digital Pathology → PFIZER LIMITED

European Commission · GB · Grant · 2020-11-26

—

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment → PFIZER LIMITED

European Commission · GB · Grant · 2020-11-12

—

Accelerating Research & Development for Advanced Therapies → PFIZER LIMITED

European Commission · GB · Grant · 2020-11-11

—

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials → PFIZER LIMITED

European Commission · GB · Grant · 2020-11-09

—

H2O Health Outcomes Observatory → PFIZER LIMITED

European Commission · GB · Grant · 2020-09-30

—

Corona Accelerated R&D in Europe → PFIZER LIMITED

European Commission · GB · Grant · 2020-08-07

—

HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS → PFIZER LIMITED

European Commission · GB · Grant · 2020-05-26

—

Stratification of Obesity Phenotypes to Optimize Future Therapy → PFIZER LIMITED

European Commission · GB · Grant · 2020-05-26

—

EUbOPEN: Enabling and Unlocking biology in the OPEN → PFIZER LIMITED

European Commission · GB · Grant · 2020-05-11

—

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory → PFIZER LIMITED

European Commission · GB · Grant · 2019-12-18

—

Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates → PFIZER LIMITED

European Commission · GB · Grant · 2019-12-17

—

PharmaLedger → PFIZER LIMITED

European Commission · GB · Grant · 2019-12-16

—

EU Patient- cEntric clinicAl tRial pLatform → PFIZER LIMITED

European Commission · GB · Grant · 2019-11-27

—

Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies → PFIZER LIMITED

European Commission · GB · Grant · 2019-09-26

—

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions → PFIZER LIMITED

European Commission · GB · Grant · 2019-08-22

—

Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials → PFIZER LIMITED

European Commission · GB · Grant · 2019-08-07

—

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed w → PFIZER LIMITED

European Commission · GB · Grant · 2019-05-06

—

Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diag → PFIZER LIMITED

European Commission · GB · Grant · 2019-04-08

—

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement → PFIZER LIMITED

European Commission · GB · Grant · 2019-03-22

—

Neurotoxicity De-Risking in Preclinical Drug Discovery → PFIZER LIMITED

European Commission · GB · Grant · 2019-03-15

—

EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells → PFIZER LIMITED

European Commission · GB · Grant · 2019-02-28

—

Biomarkers in Atopic Dermatitis and Psoriasis → PFIZER LIMITED

European Commission · GB · Grant · 2019-02-27

—

Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain → PFIZER LIMITED

European Commission · GB · Grant · 2018-12-14

—

Vaccines and Infectious Diseases in the Ageing PopuLation → PFIZER LIMITED

European Commission · GB · Grant · 2018-12-10

—

European Health Data and Evidence Network → PFIZER LIMITED

European Commission · GB · Grant · 2018-11-22

—

WEB-RADR 2 → PFIZER LIMITED

European Commission · GB · Grant · 2018-09-10

—

Research empowerment on solute carriers (ReSOLUTE) → PFIZER LIMITED

European Commission · GB · Grant · 2018-06-22

—

conect4children (COllaborative Network for European Clinical Trials For Children) → PFIZER LIMITED

European Commission · GB · Grant · 2018-06-22

—

Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production → PFIZER LIMITED

European Commission · GB · Grant · 2018-06-21

—

Ensuring the future of EUPATI beyond 2020 → PFIZER LIMITED

European Commission · GB · Grant · 2018-06-21

—

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medici → PFIZER LIMITED

European Commission · GB · Grant · 2018-06-04

—

Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections → PFIZER LIMITED

European Commission · GB · Grant · 2017-10-27

—

Liver Investigation: Testing Marker Utility in Steatohepatitis → PFIZER LIMITED

European Commission · GB · Grant · 2017-10-09

—

Rheuma Tolerance for Cure → PFIZER LIMITED

European Commission · GB · Grant · 2017-08-25

—

European Quality In Preclinical Data → PFIZER LIMITED

European Commission · GB · Grant · 2017-08-18

—

ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 → PFIZER LIMITED

European Commission · GB · Grant · 2017-05-18

—

Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 → PFIZER LIMITED

European Commission · GB · Grant · 2017-03-10

—

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 → PFIZER LIMITED

European Commission · GB · Grant · 2017-01-30

—

Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 → PFIZER LIMITED

European Commission · GB · Grant · 2016-12-22

—

REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 → PFIZER LIMITED

European Commission · GB · Grant · 2016-12-14

—

Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 → PFIZER LIMITED

European Commission · GB · Grant · 2016-10-21

—

Vaccine lot to Vaccine lot comparison by consistency testing. → PFIZER LIMITED

European Commission · GB · Grant · 2016-04-14

—

Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 → PFIZER LIMITED

European Commission · GB · Grant · 2015-12-18

—

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: → PFIZER LIMITED

European Commission · GB · Grant · 2015-09-02

—

Driving innovation in pharmaceuticals: integrated studies of physical dissolution properties of crystalline and amorphous forms using enhanced orthogo → PFIZER LIMITED

European Commission · GB · Grant · 2014-12-02

€27,000

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.